- Founded
- 2016
- Employees
- 51-100
- Total Funding
- $60.4M
Founded by Giuseppe Mazza in 2016.
About Engitix
Engitix Therapeutics is a London-based biotechnology company unlocking the extracellular matrix (ECM) as a source of novel therapeutic targets for fibrosis and cancer. Through our unique understanding of the ECM, world-class technology, and distinctive approach, we're generating insights that power the development of new, advanced therapeutics. At the heart of this work is our biological samples resource, the foundation that lets us validate these insights into organ and disease biology and turn cutting-edge science into real progress toward meaningful treatment options.
Leadership at Engitix
The team at the top of the org chart.
Giuseppe Mazza
Co-Founder and CEO
36 reports
Chris Stevenson
Chief Scientific Officer
29 reports
Amélie Fortin
Senior Director, People and Culture
1 report
Andy Roland-Price
Finance Director
3 reports
Board
Eduardo Bravo
Chairman of the Board
Mike Platt
Director
Gianluca Rosetti
Director
Sonia Quaratino
Director
Massimo Pinzani
Scientific Advisor
Mario Strazzabosco
Scientific Advisor
Open Jobs at Engitix (4)
Similar companies hiring
Top employers in Health Care